REVIEW PAPER
Physiotherapy in Kennedy’s disease
1
Studenckie Koło Naukowe przy Katedrze i Klinice Rehabilitacji, Wydział Nauk o Zdrowiu, Śląski Uniwersytet Medyczny w Katowicach
2
Katedra i Klinika Rehabilitacji, Wydział Nauk o Zdrowiu, Śląski Uniwersytet Medyczny w Katowicach
Corresponding author
Tomasz Jurys
Studenckie Koło Naukowe przy Katedrze i Klinice Rehabilitacji, Wydział Nauk o Zdrowiu, Śląski Uniwersytet Medyczny w Katowicach, Grażyńskiego, 46A, 4, 40-126 Katowice, Polska
Studenckie Koło Naukowe przy Katedrze i Klinice Rehabilitacji, Wydział Nauk o Zdrowiu, Śląski Uniwersytet Medyczny w Katowicach, Grażyńskiego, 46A, 4, 40-126 Katowice, Polska
Med Og Nauk Zdr. 2018;24(3):172-175
KEYWORDS
TOPICS
ABSTRACT
Introduction and objectives:
Kennedy’s disease is a X-linked neurodegenerative disease which first symptoms appear around 40 years old. There is no effective therapy, but the medical and the physiotherapeutic approach is concentrated on the maintaining general fitness. The aim of this review work is the presentation of the specifity of Kennedy’s disease, the analysis of health problems and the discussion about the physiotherapy process.
State of the knowledge:
Kennedy’s disease is caused by the gene mutation of androgen receptor protein. It leads to the increase of concentration of glutamine in the androgen receptor, causing the insensitivity to the androgens. The first symptoms are the pain and the muscle cramps. The weakness and the progressive muscle atrophy of the fascial and larynx muscles causes the dysarthria and the dysfagia. The lower extremity muscle artophy forces patients to using of mobility aids. In addition to the neuromuscular symptoms, the symptoms of the androgen insensitivity syndrome like the infertility, the impotence and gynaecomastia are also showed. Although the several clinical trials, there is no effective therapy. The research concernig the process of the physiotherapy provide information about the efficacy and intensity of the physical exercises.
Summary:
Kennedy’s disease concerns the whole system, therefore the process of the physiotherapy should be based on the multidirectional action. In order to minimalise the consequences of the disease, it is necessery cooperation of the members of the medical team.
Kennedy’s disease is a X-linked neurodegenerative disease which first symptoms appear around 40 years old. There is no effective therapy, but the medical and the physiotherapeutic approach is concentrated on the maintaining general fitness. The aim of this review work is the presentation of the specifity of Kennedy’s disease, the analysis of health problems and the discussion about the physiotherapy process.
State of the knowledge:
Kennedy’s disease is caused by the gene mutation of androgen receptor protein. It leads to the increase of concentration of glutamine in the androgen receptor, causing the insensitivity to the androgens. The first symptoms are the pain and the muscle cramps. The weakness and the progressive muscle atrophy of the fascial and larynx muscles causes the dysarthria and the dysfagia. The lower extremity muscle artophy forces patients to using of mobility aids. In addition to the neuromuscular symptoms, the symptoms of the androgen insensitivity syndrome like the infertility, the impotence and gynaecomastia are also showed. Although the several clinical trials, there is no effective therapy. The research concernig the process of the physiotherapy provide information about the efficacy and intensity of the physical exercises.
Summary:
Kennedy’s disease concerns the whole system, therefore the process of the physiotherapy should be based on the multidirectional action. In order to minimalise the consequences of the disease, it is necessery cooperation of the members of the medical team.
REFERENCES (28)
1.
Grunseich Ch, Fishbeck KH. Spinal and Bulbar Muscular Artophy. Neurol Clin. 2015; 33: 847–854.
2.
Kennedy WR, Alter M, Sung H. Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait. Neurology. 1968; 18(7): 671–680.
4.
Fishbeck KH. Spinal and Bulbar Muscular Atrophy Overview. J Mon Neurosci. 2016; 58: 317–320.
5.
Chahin N, Klein Ch, Mandrekar J, Sorenson E. Natural history of spinal¬-bulbar muscular atrophy. Neurology 2008; 70: 1967–1971.
6.
Gorzelnik K, Zagrajek M, Bilińska M, Lewczuk K, Sułek A, Paradow¬ski B. Choroba Kennedy’ego – opis przypadku. Pol Prz Neurol. 2015; 11(3): 132–135.
7.
Katsuno M, Banno H, Suzuki K, Adachi H, Tanaka F, Sobue G. Clinical Features and Molecular Mechanisms of Spinal and Bulbar Muscular Atrophy (SBMA). In: S.I. Ahmad (red.), Diseases of DNA Repair. New York: Landes Bioscience and Springer Science+Business Media 2010: 64–74.
8.
Weydt P, Sagnelli A, Rosenbohm A, Fratta P, Pradat PF, Ludolph A. C i wsp. Clinical Trials in Spinal and Bulbar Muscular Atrophy – Past, Present, and Future. J Mon Neurosci. 2016; 58: 379–387.
9.
Querin G, Soraru G, Pradat PF. Kennedy disease (X-linked recessive bulbospinal neuronopathy): A comprehensive review from pathophysiology to therapy. Rev Neurol. 2017; 173: 326–337.
10.
Finsterer J. Bulbar and spinal muscular atrophy (Kennedy’s disease): a review. Eur J Neurol. 2009; 16: 556–561.
11.
Banno H, Katsuno M, Suzuki K, Tanaka F, Sobue G. Pathogenesis and molecular targeted therapy and bulbar muscular atrophy (SBMA). Cell Tissue Res. 2012; 349: 313–320.
12.
Gianni S, Querin G, Pennuto. Skeletal muscle as an emerging thera¬peutic target in spinal and bulbar muscular atrophy. Clin Invest. 2014; 4(4): 293–296.
13.
Higashihara M, Sonoo M, Yamamoto T, Nagashima Y, Uesugi H, Terao Y i wsp. Evaluation of Spinal and Bulbar Muscular Atrophy by the Clustering Index Method. Muscle Nerve. 2011; 44: 539–546.
14.
Suzuki K, Katsuno M, Banno H, Takeuchi Y, Kawashima M, Suga N i wsp. The profile of motor unit number estimation (MUTE) in spinal and bulbar muscular atrophy. J Neurol Neurosurg Psychiatry. 2010; 81: 567–571.
15.
Rhodes LE, Freeman BK, Auh S, Kokkinis AD, La Pean A, Chen Ch i wsp. Clinical features of spinal and bulbar muscular atrophy. Brain 2009; 132: 3242–3251.
16.
Rocchi A, Penutto M. New Routes to Therapy for Spinal and Bulbar Muscular Atrophy. J Mon Neurosci. 2013; 50: 514–523.
17.
Ranganathan S, Fischbeck KH. Therapeutic approaches to spinal and bulbar muscular atrophy. Trends Pharmacol Sci. 2010; 31(11): 523–527.
18.
Hijikata Y, Katsuno M, Suzuki K, Hashizume A, Araki A, Yamada Sh i wsp. Treatment with Creatine Monohydrate in Spinal and Bulbar Muscular Atrophy: Protocol for a Randomized, Double-Blind, Placebo¬-Controlled Trial. JMIR Res Protoc. 2018; 7(3): e69.
19.
Dahlqvist JR, Vissing J. Exercise Therapy in Spinobulbar Muscular Atrophy and Other Neuromuscular Disorders. J Mol Neurosci. 2016; 58: 388–393.
20.
Osiński W. Nadwaga i otyłość. Aktywność fizyczna w profilaktyce i terapii. Wyd. 2. Wydawnictwo Lekarskie PZWL: Warszawa 2016.
21.
Pennuto M, Greensmith L, Pradat P. F, Soraru G. Session VI: Therapy. 210th ENMC International Workshop: Research and clinical mana¬gement of patients with spinal and bulbar muscular atrophy; 2015 Mar 27–29; Naarden, The Netherlands. Neuromuscl Disord. 2015; 25: 802–812.
22.
Heje K, Anderson G, Vissing J. High intensity training in patients with spinal and bulbar muscular atrophy. Neuromuscul Disord. 2015; 25: G.P.134.
23.
Gormley SE, Swain DP, High R, Spina RJ, Downling EA, Kotipalli US i wsp. Effect of intensity of aerobic training on VO2max. Medi Sci Sports Exerc. 2008; 40: 1336–1343.
24.
Presisler N, Andersen G, Thogersen F, Crone C, Jeppesen TD, Wibrand F i wsp. Effect of aerobic training in patients with spinal and bulbar muscular atrophy (Kennedy disease). Neurology 2009; 72: 317–323.
25.
Shrader JA, Kats I, Kokkinis A, Zampieri C, Levy E, Joe GO i wsp. A randomized controlled trial of exercise in spinal and bulbar muscular atrophy. Ann Clin Transl Neurol. 2015; 2(7): 739–747.
26.
Harris-Love MO, Fernandez-Rhodes L, Joe G, Shrader JA, Kokkinis A, La Pean Kirschner A, Auh S i wsp. Assessing Function and Endurance in Adults with Spinal and Bulbar Muscular Atrophy: Validity of the Adult Myopathy Assessment Tool. Rehabil Res Pract. 2014: 1–16.
27.
Takeuchi Y, Katsuno M, Banno H, Suzuki K, Kawashima M, Atsuta N i wsp. Walking Capacity Evaluated by the 6-Minute Walk Test in Spinal and Bulbar Muscular Atrophy. Muscle & Nerve 2008; 38: 964–971.
28.
Hashizume A, Katsuno M, Suzuki K, Banno H, Suga N, Mano T i wsp. A functional scale for spinal and bulbar muscular atrophy: Cross-sectional and longitudinal study. Neuromuscul Disord. 2015; 25: 554–562.
Share
RELATED ARTICLE
| eISSN: | 2084-4905 |
| ISSN: | 2083-4543 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
